Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 05, 2017 Filed May 9, 2017 17:23 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Exercise / conversionCommon Stock 3,498 $38.59 $134,987.82
Disclosure

SEC source: 0001140361-17-019043 · doc1.xml · nonDerivative · entry 3

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,030

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

Read SEC document
May 05, 2017 Filed May 9, 2017 17:23 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 988 $99.00 $97,812.00
Disclosure

SEC source: 0001140361-17-019043 · doc1.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,532

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
May 05, 2017 Filed May 9, 2017 17:23 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Exercise / conversionCommon Stock 988 $28.23 $27,891.24
Disclosure

SEC source: 0001140361-17-019043 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,520

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

Read SEC document
May 05, 2017 Filed May 9, 2017 17:21 UTC
Davis George EricEVP, General Counsel
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 2,500 $0.00 Strike: $38.59 $0.00
Disclosure

SEC source: 0001140361-17-019040 · doc1.xml · derivative · entry 4

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,844

Underlying: Common Stock · 2,500 shares

Expires 2018-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-a plan executed on November 2, 2016.

F4 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
May 05, 2017 Filed May 9, 2017 17:21 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 2,500 $100.34 $250,852.50
Disclosure

SEC source: 0001140361-17-019040 · doc1.xml · nonDerivative · entry 3

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,251

F2 · date: Trade made pursuant to a 10b5-a plan executed on November 2, 2016.

F3 · price: All shares were sold at the same price.

Read SEC document
May 05, 2017 Filed May 9, 2017 17:21 UTC
Davis George EricEVP, General Counsel
Exercise / conversionCommon Stock 2,500 $38.59 $96,475.00
Disclosure

SEC source: 0001140361-17-019040 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-a plan executed on November 2, 2016.

Read SEC document
May 02, 2017 Filed May 5, 2017 00:54 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 302 $96.74 $29,215.48
Disclosure

SEC source: 0001140361-17-018529 · doc1.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,532

F2 · date: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

F3 · price: All shares were sold at the same price.

Read SEC document
April 28, 2017 Filed May 5, 2017 00:54 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 302 $70.30 $21,231.81
Disclosure

SEC source: 0001140361-17-018529 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,834

F1 · date: Represents shares acquired by the reporting person pursuant to the issuer's Employee Stock Purchase Plan

Read SEC document
April 28, 2017 Filed May 9, 2017 17:19 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 302 $70.30 $21,231.81
Disclosure

SEC source: 0001140361-17-019037 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,496

F1 · date: Represents shares acquired by the reporting person pursuant to the issuer's Employee Stock Purchase Plan

Read SEC document
April 28, 2017 Filed May 9, 2017 17:21 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 302 $70.30 $21,231.81
Disclosure

SEC source: 0001140361-17-019040 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,251

F1 · date: Represents shares acquired by the reporting person on April 28, 2017, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 28, 2017 Filed May 10, 2017 19:23 UTC
Mueller BrianSVP, Corporate Controller
GrantCommon Stock 270 $70.30 $18,982.08
Disclosure

SEC source: 0001140361-17-019306 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,350

F1 · date: Represents shares acquired by the reporting person on April 28, 2017, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 28, 2017 Filed May 17, 2017 22:50 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantCommon Stock 155 $70.30 $10,897.12
Disclosure

SEC source: 0001140361-17-021241 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,826

F1 · date: Represents shares acquired by the reporting person pursuant to issuer's Employee Stock Purchase Plan.

Read SEC document
April 28, 2017 Filed May 17, 2017 22:48 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 302 $70.30 $21,231.81
Disclosure

SEC source: 0001140361-17-021239 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,494

F1 · date: Represents shares acquired by the reporting person pursuant to issuer's Employee Stock Purchase Plan.

Read SEC document
April 28, 2017 Filed May 17, 2017 22:46 UTC
BAFFI ROBERTEVP, Technical Operations
GrantCommon Stock 302 $70.30 $21,231.81
Disclosure

SEC source: 0001140361-17-021237 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,793

F1 · date: Represents shares acquired by the reporting person pursuant to issuer's Employee Stock Purchase Plan.

Read SEC document
April 27, 2017 Filed May 1, 2017 21:39 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-017667 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,423

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
April 27, 2017 Filed May 1, 2017 21:39 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $95.72 $478,600.00
Disclosure

SEC source: 0001140361-17-017667 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,194

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016

F2 · price: All shares sold at the same price.

Read SEC document
April 27, 2017 Filed May 1, 2017 21:39 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $17.33 $86,650.00
Disclosure

SEC source: 0001140361-17-017667 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016

Read SEC document
April 25, 2017 Filed Apr 27, 2017 22:49 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-017203 · doc1.xml · derivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,423

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
April 25, 2017 Filed Apr 27, 2017 22:49 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $94.00 $470,000.00
Disclosure

SEC source: 0001140361-17-017203 · doc1.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,194

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016

F2 · price: All shares sold at the same price.

Read SEC document
April 25, 2017 Filed Apr 27, 2017 22:49 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $17.33 $86,650.00
Disclosure

SEC source: 0001140361-17-017203 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 243,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016

Read SEC document
April 04, 2017 Filed Apr 6, 2017 21:28 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 3,000 $0.00 Strike: $14.39 $0.00
Disclosure

SEC source: 0001140361-17-015150 · doc1.xml · derivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,000

Underlying: Common Stock · 3,000 shares

Expires 2019-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
April 04, 2017 Filed Apr 6, 2017 21:28 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 3,000 $14.39 $43,170.00
Disclosure

SEC source: 0001140361-17-015150 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 29, 2017 Filed Mar 31, 2017 21:34 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 3,890 $89.15 $346,793.50
Disclosure

SEC source: 0001140361-17-014215 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,532

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 18, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:48 UTC
Davis George EricEVP, General Counsel
GrantStock Option (Right to buy Common Stock) · Derivative 36,280 $0.00 Strike: $87.42 $0.00
Disclosure

SEC source: 0001140361-17-013325 · doc1.xml · derivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,820

Underlying: Common Stock · 36,280 shares

Expires 2027-03-21

F2 · derivative.exercise_date: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:48 UTC
Davis George EricEVP, General Counsel
GrantCommon Stock 11,220 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-013325 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,949

F1 · price: Restricted stock units granted on March 22, 2017. Price not applicable.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:46 UTC
Mueller BrianSVP, Corporate Controller
GrantStock Option (Right to buy Common Stock) · Derivative 7,740 $0.00 Strike: $87.42 $0.00
Disclosure

SEC source: 0001140361-17-013321 · doc1.xml · derivative · entry 2

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,740

Underlying: Common Stock · 7,740 shares

Expires 2027-03-21

F2 · derivative.exercise_date: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:46 UTC
Mueller BrianSVP, Corporate Controller
GrantCommon Stock 4,790 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-013321 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,080

F1 · price: Restricted stock units granted on March 22, 2017. Price not applicable.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:47 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantStock Option (Right to buy Common Stock) · Derivative 144,050 $0.00 Strike: $87.42 $0.00
Disclosure

SEC source: 0001140361-17-013323 · doc1.xml · derivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,050

Underlying: Common Stock · 144,050 shares

Expires 2027-03-21

F2 · derivative.exercise_date: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:47 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
GrantCommon Stock 44,520 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-013323 · doc1.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,194

F1 · price: Restricted stock units granted on March 22, 2017. Price not applicable.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:45 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantStock Option (Right to buy Common Stock) · Derivative 64,030 $0.00 Strike: $87.42 $0.00
Disclosure

SEC source: 0001140361-17-013319 · doc1.xml · derivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,030

Underlying: Common Stock · 64,030 shares

Expires 2027-03-21

F2 · derivative.exercise_date: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:45 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 19,790 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-013319 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,192

F1 · price: Restricted stock units granted on March 22, 2017. Price not applicable.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:43 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantStock Option (Right to buy Common Stock) · Derivative 39,480 $0.00 Strike: $87.42 $0.00
Disclosure

SEC source: 0001140361-17-013317 · doc1.xml · derivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,480

Underlying: Common Stock · 39,480 shares

Expires 2027-03-21

F2 · derivative.exercise_date: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:43 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 12,200 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-013317 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,422

F1 · price: Restricted stock units granted on March 22, 2017. Price not applicable.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:41 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantStock Option (Right to buy Common Stock) · Derivative 39,480 $0.00 Strike: $87.42 $0.00
Disclosure

SEC source: 0001140361-17-013315 · doc1.xml · derivative · entry 2

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,480

Underlying: Common Stock · 39,480 shares

Expires 2027-03-21

F2 · derivative.exercise_date: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:41 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
GrantCommon Stock 12,200 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-013315 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,671

F1 · price: Restricted stock units granted on March 22, 2017. Price not applicable.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:40 UTC
BAFFI ROBERTEVP, Technical Operations
GrantStock Option (Right to buy Common Stock) · Derivative 38,420 $0.00 Strike: $87.42 $0.00
Disclosure

SEC source: 0001140361-17-013313 · doc1.xml · derivative · entry 3

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,420

Underlying: Common Stock · 38,420 shares

Expires 2027-03-21

F2 · derivative.exercise_date: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.

Read SEC document
March 22, 2017 Filed Mar 24, 2017 22:40 UTC
BAFFI ROBERTEVP, Technical Operations
GrantCommon Stock 11,870 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-013313 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,491

F1 · price: Restricted stock units granted on March 22, 2017. Price not applicable.

Read SEC document
March 16, 2017 Filed Mar 17, 2017 22:32 UTC
Mueller BrianSVP, Corporate Controller
Tax withholdingCommon Stock 376 $90.96 $34,200.96
Disclosure

SEC source: 0001140361-17-012647 · doc1.xml · nonDerivative · entry 2

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,290

Read SEC document
March 16, 2017 Filed Mar 17, 2017 22:31 UTC
Davis George EricEVP, General Counsel
SaleCommon Stock 2,238 $91.96 $205,806.48
Disclosure

SEC source: 0001140361-17-012645 · doc1.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,729

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 2, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 16, 2017 Filed Mar 17, 2017 22:30 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
SaleCommon Stock 1,989 $91.96 $182,908.44
Disclosure

SEC source: 0001140361-17-012643 · doc1.xml · nonDerivative · entry 2

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,471

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 16, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 16, 2017 Filed Mar 17, 2017 22:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-012641 · doc1.xml · derivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,423

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document
March 16, 2017 Filed Mar 17, 2017 22:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
SaleCommon Stock 5,000 $91.96 $459,800.00
Disclosure

SEC source: 0001140361-17-012641 · doc1.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,674

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F2 · price: All shares were sold at the same price.

Read SEC document
March 16, 2017 Filed Mar 17, 2017 22:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,000 $71.33 $356,650.00
Disclosure

SEC source: 0001140361-17-012641 · doc1.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,674

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:36 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Tax withholdingCommon Stock 3,288 $92.50 $304,140.00
Disclosure

SEC source: 0001140361-17-012655 · doc1.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,222

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:34 UTC
BAFFI ROBERTEVP, Technical Operations
Tax withholdingCommon Stock 3,289 $92.50 $304,232.50
Disclosure

SEC source: 0001140361-17-012649 · doc1.xml · nonDerivative · entry 1

BAFFI ROBERT · CIK 0001274826 · EVP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,621

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:35 UTC
FUCHS HENRY JPresident, Worldwide R&D
Tax withholdingCommon Stock 5,116 $92.50 $473,230.00
Disclosure

SEC source: 0001140361-17-012653 · doc1.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,402

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:32 UTC
Mueller BrianSVP, Corporate Controller
Tax withholdingCommon Stock 336 $92.50 $31,080.00
Disclosure

SEC source: 0001140361-17-012647 · doc1.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · SVP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,666

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:31 UTC
Davis George EricEVP, General Counsel
Tax withholdingCommon Stock 2,995 $92.50 $277,037.50
Disclosure

SEC source: 0001140361-17-012645 · doc1.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,967

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:30 UTC
SPIEGELMAN DANIEL KEVP, Chief Financial Officer
Tax withholdingCommon Stock 4,301 $92.50 $397,842.50
Disclosure

SEC source: 0001140361-17-012643 · doc1.xml · nonDerivative · entry 1

SPIEGELMAN DANIEL K · CIK 0001238403 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,460

Read SEC document
March 15, 2017 Filed Mar 17, 2017 22:27 UTC
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative 5,000 $0.00 Strike: $17.33 $0.00
Disclosure

SEC source: 0001140361-17-012641 · doc1.xml · derivative · entry 7

BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,423

Underlying: Common Stock · 5,000 shares

Expires 2017-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 15, 2016.

F3 · balance_after: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.